1,3-benzoxazolyl derivatives as kinaseinhibitors

Details for Australian Patent Application No. 2004281879 (hide)

Owner Merck Patent GmbH

Inventors Jonczyk, Alfred; Rautenberg, Wilfried; Stahle, Wolgang

Agent Davies Collison Cave

Pub. Number AU-B-2004281879

PCT Pub. Number WO2005/037829

Priority 103 44 223.5 24.09.03 DE

Filing date 1 September 2004

Wipo publication date 28 April 2005

Acceptance publication date 7 April 2011

International Classifications

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037829 Priority application(s): WO2005/037829

7 April 2011 Application Accepted

  Published as AU-B-2004281879

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281885-Method for the production of a hydraulic binding agent, a structural component, use thereof and device therefor

2004281875-Large-capacity vehicle for transporting people, especially a rail vehicle, comprising carriages that are connected in an articulated manner